Submit or Track your Manuscript LOG-IN

mir-16-5p as a Suitable Reference Gene for Normalization of Quantitative Real Time PCR in Acute Lymphoblastic Leukemia

mir-16-5p as a Suitable Reference Gene for Normalization of Quantitative Real Time PCR in Acute Lymphoblastic Leukemia

Samiah Shahid1,Jawaria Shaheen1, Wajeehah Shahid2, M. Waheed Akhtar1,3 and Saima Sadaf1,*

1Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore-54590
2Department of Physics, The University of Lahore, Lahore
3School of Biological Sciences, University of the Punjab, Lahore-54590

*      Corresponding author: [email protected]

 

Fig. 1.

Comparison of quantitative real time PCR for RNU6-2, cel-mir-39-1 and mir-16-5p as reference genes determined through qPCR. Boxes represent mean and standard deviation and whiskers represent minimum and maximum values.

Fig. 2.

Determination of quantification cycle (Cq value) of the three candidate reference genes RNU6-2 (A) cel-mir-39-1 (B) and mir-16-5p (C) in the patient and normal control samples of ALL determined through qPCR. The values for each distribution are given as mean ± standard deviation as shown in box and whiskers plot.

Fig. 3.

A, melt curve analysis of candidate reference genes for normalization of qPCR in ALL. A singe peak at melting temperature 75.5°C showed amplified products are specific and no non-specific amplification were occurred (a, specific amplification curves; b, NTC-no template control); B, amplification curves of candidate reference genes through qPCR in ALL showing relative fluorescence unit (RFU) of more than 103.

Fig. 4.

GeNorm analysis of average expression stability by qBase+ software: GeNorm results (M values) for candidate reference genes analyzed (normalized against c. elegans mir-39 as spike in control) indicated mir-16-5p as the most suitable reference gene with highest expression stability.

Pakistan Journal of Zoology

December

Pakistan J. Zool., Vol. 56, Iss. 6, pp. 2501-3000

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe